We are live on ! Find out more
MRVI icon

Maravai LifeSciences
MRVI

219 hedge funds and large institutions have $1.79B invested in Maravai LifeSciences in 2023 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 92 increasing their positions, 59 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 59

32% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 31

3% more funds holding

Funds holding: 212 → 219 (+7)

0.92% more ownership

Funds ownership: 96.32% → 97.24% (+0.92%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less capital invested

Capital invested by funds: $1.81B → $1.79B (-$14.7M)

16% less call options, than puts

Call options by funds: $1.04M | Put options by funds: $1.24M

Holders
219
Holders Change
+7
Holders Change %
+3.3%
% of All Funds
3.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
41
Increased
92
Reduced
59
Closed
31
Calls
$1.04M
Puts
$1.24M
Net Calls
-$201K
Net Calls Change
+$204K

Top Buyers

Rank Fund Capital Flow
1
1WCM
12 West Capital Management
New York
+$36.9M
2
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
+$28.9M
3
UBS AM
UBS AM
Illinois
+$19.9M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$12.6M
5
MIIM
Mesirow Institutional Investment Management
Illinois
+$11.7M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$37.1M
2
Select Equity Group
Select Equity Group
New York
-$36.1M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$25.4M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$18.5M
5
Norges Bank
Norges Bank
Norway
-$15.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
VCM
201
Versant Capital Management
Arizona
$957 -$359 -25 -27%
RA
202
Rise Advisors
New York
$701 – – –
NA
203
NewEdge Advisors
Louisiana
$644 -$531 -37 -45%
Northwestern Mutual Wealth Management
204
Northwestern Mutual Wealth Management
Wisconsin
$518 +$302 +21 +131%
SPIA
205
Steward Partners Investment Advisory
New York
$280 – – –
BWL
206
Bogart Wealth LLC
Virginia
$280 +$287 +20 New
SC
207
Schubert & Co
Texas
$141 +$14 +1 +11%
ASN
208
Advisory Services Network
Georgia
$140 – – –
FFA
209
Farther Finance Advisors
California
$140 +$144 +10 New
JWA
210
JFS Wealth Advisors
Pennsylvania
$127 +$72 +5 +125%
GFWA
211
Grey Fox Wealth Advisors
Delaware
$98 – – –
SIC
212
SJS Investment Consulting
Ohio
$85 +$43 +3 +100%
AF
213
Advisornet Financial
Minnesota
$42 -$57 -4 -57%
DI
214
Disciplined Investments
Oklahoma
$42 +$14 +1 +50%
TWA
215
TCI Wealth Advisors
Arizona
$15 +$14 +1 New
Select Equity Group
216
Select Equity Group
New York
– -$36.1M -2,524,793 Closed
Balyasny Asset Management
217
Balyasny Asset Management
Illinois
– -$25.4M -1,776,511 Closed
California Public Employees Retirement System
218
California Public Employees Retirement System
California
– -$3.53M -246,995 Closed
First Trust Advisors
219
First Trust Advisors
Illinois
– -$3.34M -233,355 Closed
Public Sector Pension Investment Board (PSP Investments)
220
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
– -$3.33M -233,000 Closed
SEC
221
Seven Eight Capital
New York
– -$2.54M -177,480 Closed
ECM
222
ExodusPoint Capital Management
New York
– -$2.1M -146,667 Closed
QT
223
Quantbot Technologies
New York
– -$1.82M -127,030 Closed
WMSA
224
Weiss Multi-Strategy Advisers
New York
– -$1.52M -105,950 Closed
GCP
225
GSA Capital Partners
United Kingdom
– -$787K -54,976 Closed
6 7 8
9
10

MRVI Hedge Fund Activity: Q1 2023 in Review

219 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q1 2023, worth a combined $1.79B — down 0.82% from $1.81B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new MRVI positions and 31 closed out — a net gain of 10 holders — while 92 added to existing stakes and 59 trimmed.

The largest buyer was 12 West Capital Management, opening a new position worth an estimated $36.9M. The largest seller was Millennium Management, cutting an estimated $37.1M.

  • 219 institutional investors held Maravai LifeSciences (MRVI) as of Q1 2023, up from 212 in Q4 2022.
  • Funds reported $1.79B of Maravai LifeSciences stock for Q1 2023, down 0.82% quarter-over-quarter.
  • 41 funds opened new Maravai LifeSciences positions in Q1 2023 and 31 closed out, a net change of +10 holders.
  • The largest Maravai LifeSciences buyer in Q1 2023 was 12 West Capital Management, an estimated $36.9M added.
  • The largest Maravai LifeSciences seller in Q1 2023 was Millennium Management, an estimated $37.1M sold.

Based on aggregated 13F filings for Q1 2023.